Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2516399329', 'doi': None, 'title': 'EXPERIMENTAL RESEARCH OF EFFECTIVENESS OF siRNA- Her-2/neu ON DRUG SENSITIVITY OF Her-2/neu-OVEREXPRESSING LUNG ADENOCARCINOMA CELL LINE', 'display_name': 'EXPERIMENTAL RESEARCH OF EFFECTIVENESS OF siRNA- Her-2/neu ON DRUG SENSITIVITY OF Her-2/neu-OVEREXPRESSING LUNG ADENOCARCINOMA CELL LINE', 'publication_year': 2006, 'publication_date': '2006-01-01', 'ids': {'openalex': 'https://openalex.org/W2516399329', 'mag': '2516399329'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'http://www.cqvip.com/QK/85190X/200603/22811834.html', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306542058', 'display_name': '中国癌症研究:英文版', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': [], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5009800029', 'display_name': '任淑华', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': '任淑华', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5079560204', 'display_name': '王井伟', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': '王井伟', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5059460384', 'display_name': '曲平', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': '曲平', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5058830515', 'display_name': 'Y. Liu', 'orcid': 'https://orcid.org/0000-0002-3576-7004'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': '刘义', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5076699095', 'display_name': 'Wei Zhang', 'orcid': 'https://orcid.org/0000-0003-2065-2535'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': '张伟', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5087246436', 'display_name': 'Lin Zhang', 'orcid': 'https://orcid.org/0000-0002-1337-2538'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': '张林', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 61}, 'biblio': {'volume': '18', 'issue': '3', 'first_page': '173', 'last_page': '176'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10417', 'display_name': 'Advancements in Lung Cancer Research', 'score': 0.9793, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10417', 'display_name': 'Advancements in Lung Cancer Research', 'score': 0.9793, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11482', 'display_name': 'RNA Methylation and Modification in Gene Expression', 'score': 0.9735, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12996', 'display_name': 'Engineering Bacteria for Cancer Treatment', 'score': 0.9578, 'subfield': {'id': 'https://openalex.org/subfields/1305', 'display_name': 'Biotechnology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/lipofectamine', 'display_name': 'Lipofectamine', 'score': 0.8844652}, {'id': 'https://openalex.org/keywords/rna-methylation', 'display_name': 'RNA methylation', 'score': 0.500994}, {'id': 'https://openalex.org/keywords/oncogene-addiction', 'display_name': 'Oncogene Addiction', 'score': 0.50002}], 'concepts': [{'id': 'https://openalex.org/C49923114', 'wikidata': 'https://www.wikidata.org/wiki/Q17139621', 'display_name': 'Lipofectamine', 'level': 5, 'score': 0.8844652}, {'id': 'https://openalex.org/C22615655', 'wikidata': 'https://www.wikidata.org/wiki/Q203221', 'display_name': 'Small interfering RNA', 'level': 4, 'score': 0.85566294}, {'id': 'https://openalex.org/C54009773', 'wikidata': 'https://www.wikidata.org/wiki/Q1429031', 'display_name': 'Transfection', 'level': 3, 'score': 0.7750596}, {'id': 'https://openalex.org/C2778239845', 'wikidata': 'https://www.wikidata.org/wiki/Q412415', 'display_name': 'Cisplatin', 'level': 3, 'score': 0.76364505}, {'id': 'https://openalex.org/C190283241', 'wikidata': 'https://www.wikidata.org/wiki/Q14599311', 'display_name': 'Apoptosis', 'level': 2, 'score': 0.6574804}, {'id': 'https://openalex.org/C88634738', 'wikidata': 'https://www.wikidata.org/wiki/Q24769543', 'display_name': 'Annexin', 'level': 3, 'score': 0.59416914}, {'id': 'https://openalex.org/C153911025', 'wikidata': 'https://www.wikidata.org/wiki/Q7202', 'display_name': 'Molecular biology', 'level': 1, 'score': 0.5851495}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.47498932}, {'id': 'https://openalex.org/C81885089', 'wikidata': 'https://www.wikidata.org/wiki/Q189082', 'display_name': 'Cell culture', 'level': 2, 'score': 0.46553388}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.45708466}, {'id': 'https://openalex.org/C2781018059', 'wikidata': 'https://www.wikidata.org/wiki/Q207609', 'display_name': 'Oncogene', 'level': 4, 'score': 0.44666865}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.3469146}, {'id': 'https://openalex.org/C29537977', 'wikidata': 'https://www.wikidata.org/wiki/Q188941', 'display_name': 'Cell cycle', 'level': 3, 'score': 0.15132758}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.14541954}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.08511776}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.0703488}, {'id': 'https://openalex.org/C54355233', 'wikidata': 'https://www.wikidata.org/wiki/Q7162', 'display_name': 'Genetics', 'level': 1, 'score': 0.0}, {'id': 'https://openalex.org/C92087593', 'wikidata': 'https://www.wikidata.org/wiki/Q427389', 'display_name': 'Vector (molecular biology)', 'level': 4, 'score': 0.0}, {'id': 'https://openalex.org/C40767141', 'wikidata': 'https://www.wikidata.org/wiki/Q285697', 'display_name': 'Recombinant DNA', 'level': 3, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'http://www.cqvip.com/QK/85190X/200603/22811834.html', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306542058', 'display_name': '中国癌症研究:英文版', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.66, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3150794847', 'https://openalex.org/W3146037545', 'https://openalex.org/W3032334722', 'https://openalex.org/W3031957879', 'https://openalex.org/W3031948077', 'https://openalex.org/W3031382882', 'https://openalex.org/W3030877899', 'https://openalex.org/W3029295238', 'https://openalex.org/W2734816622', 'https://openalex.org/W2463060140', 'https://openalex.org/W2419534933', 'https://openalex.org/W2418472083', 'https://openalex.org/W2395497198', 'https://openalex.org/W2387408325', 'https://openalex.org/W2376302752', 'https://openalex.org/W2373824398', 'https://openalex.org/W2373398966', 'https://openalex.org/W2217204039', 'https://openalex.org/W2182481622', 'https://openalex.org/W215810210'], 'abstract_inverted_index': {'在表示上的客观': [0], 'Her-2/neu': [1, 7, 43, 47, 51, 91], '蛋白质在肺腺癌被表明了。它的过去表示经常显示差的预后;抵抗到化学疗法的代理人。纸是探索双': [2], 'stranded': [3], '的有效性的这的目的在': [4], 'Her-2/neu-overexpressing': [5], '肺腺癌房间的药敏感上指向': [6], 'oncogene': [8], '的短禁止的': [9], 'RNA': [10], '(siRNA': [11], ')': [12, 24, 28, 75], '。方法肺腺癌房间线': [13], 'calu-3': [14, 96], '是有': [15], 'siRNAs': [16], '的': [17, 29, 52], 'transfected': [18, 30], '提出的': [19], 'LipofectAMINE': [20], '2000,;Her-2/neu': [21], '蛋白质;P-gp': [22], '被流动血细胞计数(FCM': [23], '决定。到': [25], 'cisplatin': [26], '(CDDP': [27], '房间的': [31, 97], 'chemosensitivity': [32, 98], '被': [33], 'MTT': [34], '测量。房间': [35], 'apoptosis': [36, 41, 87], '察觉工具包(Annexin': [37], 'V': [38], '方法)': [39], '被用来检验导致的': [40], '评估的药。极大地指向': [42], '的结果': [44], 'siRNA': [45, 53, 79, 89, 94], '减少了': [46], '蛋白质的房间表面表示;没在': [48], 'P-gp': [49], '上有效果。因而在有指向': [50], '的联合的': [54], 'CDDP': [55, 83], '的禁止的率是(67.1': [56], '±': [57, 62, 67, 72], '2': [58, 73], '.3': [59], ')%': [60, 65, 70], '当禁止的率是时(48.1': [61], '3': [63], '.5': [64], ',(46.3': [66], '5': [68], '.9': [69, 74], ';(50.2': [71], '在未经治疗的控制的': [76], '%': [77], ',空向量;无关的': [78], '分别地组织。当时,': [80], 'FCM': [81], '结果证明对待,': [82], '与': [84], 'siRNAs-Her-2/neu': [85], '结合了的房间的': [86], '率被提高与无关的': [88], '相比组;倒空向量组。指向': [90], '的结论顺序': [92], 'specific': [93], '能够提高': [95], '到': [99], 'cisplatin。': [100]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2516399329', 'counts_by_year': [], 'updated_date': '2024-09-19T00:15:14.314451', 'created_date': '2016-09-16'}